Literature DB >> 12153591

The management of primary hyperparathyroidism.

M Davies1, W D Fraser, D J Hosking.   

Abstract

Recent improvements in parathyroid imaging have led to renewed interest in the criteria for, and the surgical approach to, parathyroidectomy. It therefore seemed appropriate to review current evidence relating to the evaluation and management of primary hyperparathyroidism for those working within a general endocrine service. The recommendations are based on an electronic search spanning the past decade using the search terms hyperparathyroidism, management and parathyroidectomy/surgery, but we have also included key publications outside this period. The findings have been graded systematically (Appendix), according to the quality of the information available, to indicate the level of evidence on which they are based.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12153591     DOI: 10.1046/j.1365-2265.2002.01581.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

1.  Role of ultrasonography in the management of patients with primary hyperparathyroidism: retrospective comparison with technetium-99m sestamibi scintigraphy.

Authors:  Giovanni Mariano Vitetta; Pierluigi Neri; Andrea Chiecchio; Alessandro Carriero; Stefano Cirillo; Annalisa Balbo Mussetto; Alessandra Codegone
Journal:  J Ultrasound       Date:  2014-01-31

Review 2.  Hyperparathyroidism in the elderly patient.

Authors:  Rebecca Sims; Charanjeit Ubhi; David Hosking
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

3.  Plasmapheresis-induced hypercalcaemia.

Authors:  Anas-Alwogud Abdelmogheth; Islam El-Baroudy; Saif Al-Yaaruby
Journal:  Sultan Qaboos Univ Med J       Date:  2013-02-27

4.  "Silent" kidney stones in "asymptomatic" primary hyperparathyroidism-a comparison of multidetector computed tomography and ultrasound.

Authors:  Andreas Selberherr; Marcus Hörmann; Gerhard Prager; Philipp Riss; Christian Scheuba; Bruno Niederle
Journal:  Langenbecks Arch Surg       Date:  2016-10-12       Impact factor: 3.445

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.